Cheryl L. Cohen - 30 Jun 2021 Form 4 Insider Report for Aerpio Pharmaceuticals, Inc. (WHWK)

Reporting relationship: Director
Issuer ticker: WHWK
Reported as of: 30 Jun 2021
Net transaction value: +$12,373
SEC form: 4
Accepted by SEC: 02 Jul 2021, 17:34:09 UTC
Prior SEC filing: 22 Jun 2021
Next SEC filing: 06 Jul 2021
Source filing: View source filing
Reporting owner signature: /s/ Joseph Gardner, Attorney in Fact

Key filing fact

Cheryl L. Cohen filed Form 4 for Aerpio Pharmaceuticals, Inc. (WHWK) on 02 Jul 2021.

Key facts

This page summarizes Cheryl L. Cohen's Form 4 filing for Aerpio Pharmaceuticals, Inc. (WHWK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jul 2021, 17:34.

Change

Previous filing in this sequence was filed on 22 Jun 2021.
Current net transaction value: +$12,373.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AADI transaction

Common Stock

Award

Transaction value: $12,373
Shares: +8,140
Change %: +101%
Price: $1.52
Shares after: 16,160
Date: 30 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021.